MoneyWorks4Me

Supriya Lifescience - Quaterly Results

12 Aug 2022 Evaluate
The sales for the June 2022 quarter moved up 31.73% to Rs. 1013.55 millions as compared to Rs. 769.42 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 226.27% to Rs. 252.50  millions  from Rs. 77.39 millions in previous same quarter.Operating profit surged to 336.03 millions from the corresponding previous quarter of 173.92 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1013.55 769.42 31.73 1013.55 769.42 31.73 5300.49 3912.45 35.48
Other Income 23.57 19.39 21.56 23.57 19.39 21.56 75.77 49.77 52.24
PBIDT 336.03 173.92 93.21 336.03 173.92 93.21 2215.62 1781.51 24.37
Interest 5.81 9.74 -40.35 5.81 9.74 -40.35 41.98 40.80 2.89
PBDT 330.22 164.18 101.13 330.22 164.18 101.13 2173.64 1740.71 24.87
Depreciation 28.85 24.77 16.47 28.85 24.77 16.47 101.18 67.61 49.65
PBT 301.37 139.41 116.18 301.37 139.41 116.18 2072.46 1673.10 23.87
TAX 48.87 62.02 -21.20 48.87 62.02 -21.20 554.35 437.16 26.81
Deferred Tax 3.00 45.97 -93.47 3.00 45.97 -93.47 32.46 6.94 367.72
PAT 252.50 77.39 226.27 252.50 77.39 226.27 1518.11 1235.94 22.83
Equity 160.96 146.37 9.97 160.96 146.37 9.97 160.97 146.37 9.97
PBIDTM(%) 33.15 22.60 46.67 33.15 22.60 46.67 41.80 45.53 -8.20
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..